MYCOKETIDES: NOVEL M TUBERCULOSIS PKS12 PRODUCT PRESENTED BY CD1C TO T CELLS
MYCOKETIDES: NOVEL M TUBERCULOSIS PKS12 PRODUCT PRESENTED BY CD1C TO T CELLS
批准号:
7369321
负责人:
DAVID MOODY
金额:
$1.54万
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-07-01 至 2007-06-30
中文摘要
点击翻译按钮获取中文摘要
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. Study of the lipid targets of CD1c-mediated T cell responses recently identified a mycobacterial phospholipid antigen whose carbohydrate structure precisely corresponded to mammalian mannosyl b-1-phosphodolichols (MPD), but contained an unusual lipid moiety. Here we show that this T cell antigen is a member of a family of branched, alkane lipids that vary in length (C30-34) and are produced by M. tuberculosis, M. bovis Bacille-Calmette-Guerin and other mycobacteria that grow within cells. Analysis of the fine structures of these mycobacterial antigens showed that the chemical features that distinguished them from mammalian MPDs were necessary for activation of CD1c-restricted T cells, but could not be accounted for by any known lipid biosynthetic pathway. Metabolic labeling and mass spectrometric analyses suggested a mechanism for elongating lipids in C5 increments by strictly alternating incorporation of C2 and C3 units, rather than isopentenyl pyrophosphate condensation. Inspection of the M. tuberculosis genome identified one gene pks12, which is predicted to make the largest protein in the proteome and to contain 12 catalytic domains necessary to carry out this multi-step synthesis. Genetic deletion and complementation showed that PKS12 was necessary and sufficient for antigen production and the resulting CD1c-mediated T cell activation, but did not affect synthesis of true isoprenols. These studies establish the genetic and enzymatic basis for a previously unknown type of mycobacterial polyketide, designated mycoketide, which represents a lipidic pathogen associated molecular pattern that allows mycobacterial recognition by the human immune system.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
QUANTIFICATION OF DRUGS OF ABUSE AND RELATED COMPOUNDS IN BIOLOGICAL SPECIMENS
-
批准号:10286896
-
项目类别:
-
资助金额:$23.18万
-
财政年份:2019
-
负责人:DAVID MOODY
-
依托单位:
IGF::OT::IGF. QUANTIFICATION OF DRUGS OF ABUSE AND RELATED SUBSTANCES IN BIOLOGICAL SPECIMENS. BASE CONTRACT AWARD POP: MARCH 14, 2019 THROUGH MARCH 13, 2020. N01DA-19-8951.
-
批准号:10044270
-
项目类别:
-
资助金额:$23.11万
-
财政年份:2019
-
负责人:DAVID MOODY
-
依托单位:
IGF::OT::IGF. QUANTIFICATION OF DRUGS OF ABUSE AND RELATED SUBSTANCES IN BIOLOGICAL SPECIMENS. BASE CONTRACT AWARD POP: MARCH 14, 2019 THROUGH MARCH 13, 2020. N01DA-19-8951.
-
批准号:10591464
-
项目类别:
-
资助金额:$23.13万
-
财政年份:2019
-
负责人:DAVID MOODY
-
依托单位:
MASS SPECTROMETRY OF ANTIGENIC LIPOPEPTIDES
-
批准号:8365527
-
项目类别:
-
资助金额:$0.57万
-
财政年份:2011
-
负责人:DAVID MOODY
-
依托单位:
MASS SPECTROMETRY OF ANTIGENIC LIPOPEPTIDES
-
批准号:8170892
-
项目类别:
-
资助金额:$1.05万
-
财政年份:2010
-
负责人:DAVID MOODY
-
依托单位:
MASS SPECTROMETRY OF ANTIGENIC LIPOPEPTIDES: HIV
-
批准号:7955919
-
项目类别:
-
资助金额:$0.58万
-
财政年份:2009
-
负责人:DAVID MOODY
-
依托单位:
MYCOKETIDES: NOVEL M TUBERCULOSIS PKS12 PRODUCT PRESENTED BY CD1C TO T CELLS
-
批准号:7955939
-
项目类别:
-
资助金额:$0.74万
-
财政年份:2009
-
负责人:DAVID MOODY
-
依托单位:
MYCOKETIDES: M TUBERCULOSIS PKS12 PRODUCT PRESENTED BY CD1C TO T CELLS: AIDS OI
-
批准号:7723043
-
项目类别:
-
资助金额:$0.85万
-
财政年份:2008
-
负责人:DAVID MOODY
-
依托单位:
MASS SPECTROMETRY OF ANTIGENIC LIPOPEPTIDES: HIV
-
批准号:7723007
-
项目类别:
-
资助金额:$0.71万
-
财政年份:2008
-
负责人:DAVID MOODY
-
依托单位:
MASS SPECTROMETRY OF ANTIGENIC LIPOPEPTIDES: HIV
-
批准号:7602001
-
项目类别:
-
资助金额:$2.51万
-
财政年份:2007
-
负责人:DAVID MOODY
-
依托单位:
MYCOKETIDES: M TUBERCULOSIS PKS12 PRODUCT PRESENTED BY CD1C TO T CELLS: AIDS OI
-
批准号:7602037
-
项目类别:
-
资助金额:$3.01万
-
财政年份:2007
-
负责人:DAVID MOODY
-
依托单位:
ANALYSIS OF MYCOBACTERIUM ANTIGENS BY VIBRATIONALLY COOLED MALDI FTMS
-
批准号:7369219
-
项目类别:
-
资助金额:$0.41万
-
财政年份:2006
-
负责人:DAVID MOODY
-
依托单位:
MASS SPECTROMETRY OF ANTIGENIC LIPOPEPTIDES: HIV
-
批准号:7369264
-
项目类别:
-
资助金额:$1.49万
-
财政年份:2006
-
负责人:DAVID MOODY
-
依托单位:
ANALYSIS OF MYCOBACTERIUM ANTIGENS BY VIBRATIONALLY COOLED MALDI FTMS
-
批准号:7182174
-
项目类别:
-
资助金额:$0.41万
-
财政年份:2005
-
负责人:DAVID MOODY
-
依托单位:
MASS SPECTROMETRY OF ANTIGENIC LIPOPEPTIDES: HIV
-
批准号:7182219
-
项目类别:
-
资助金额:$1.48万
-
财政年份:2005
-
负责人:DAVID MOODY
-
依托单位:
MYCOKETIDES: NOVEL M TUBERCULOSIS PKS12 PRODUCT PRESENTED BY CD1C TO T CELLS
-
批准号:7182276
-
项目类别:
-
资助金额:$1.53万
-
财政年份:2005
-
负责人:DAVID MOODY
-
依托单位:
MASS SPECTROMETRY OF ANTIGENIC LIPOPEPTIDES: HIV
-
批准号:6978523
-
项目类别:
-
资助金额:$0.57万
-
财政年份:2004
-
负责人:DAVID MOODY
-
依托单位:
STRUCTURAL ELUCIDATION CD1A ANTIGEN FROM MYCOBACTERIUM TUBERCULOSIS
-
批准号:6978471
-
项目类别:
-
资助金额:$0.71万
-
财政年份:2004
-
负责人:DAVID MOODY
-
依托单位:
ANALYSIS OF MYCOBACTERIUM ANTIGENS BY VIBRATIONALLY COOLED MALDI FTMS
-
批准号:6978472
-
项目类别:
-
资助金额:$0.18万
-
财政年份:2004
-
负责人:DAVID MOODY
-
依托单位:
CORE--TECHNICAL
-
批准号:6564021
-
项目类别:
-
资助金额:$15.76万
-
财政年份:2001
-
负责人:DAVID MOODY
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Novel-miR-1134调控LHCGR的表达介导拟
穴青蟹卵巢发育的机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2025
-
负责人:崔文晓
-
依托单位:
novel-miR75靶向OPR2,CA2和STK基因调控人参真菌胁迫响应的分子机制研究
-
批准号:82304677
-
项目类别:青年科学基金项目
-
资助金额:30.00万元
-
批准年份:2023
-
负责人:边兴博
-
依托单位:
海南广藿香Novel17-GSO1响应p-HBA调控连作障碍的分子机制
-
批准号:82304658
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:刘亚
-
依托单位:
白术多糖通过novel-mir2双靶向TRADD/MLKL缓解免疫抑制雏鹅的胸腺程序性坏死
-
批准号:32102747
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:李婉雁
-
依托单位:
novel_circ_001042/miR-298-5p/Capn1轴调节线粒体能量代谢在先天性肛门直肠畸形发生中的作用机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:55万元
-
批准年份:2021
-
负责人:唐晓冰
-
依托单位:
novel-miR-59靶向HMGAs介导儿童早衰症细胞衰老的作用及机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:58万元
-
批准年份:2021
-
负责人:张瑜
-
依托单位:
novel_circ_008138/rno-miR-374-3p/SFRP4调控Wnt信号通路参与先天性肛门直肠畸形发生的分子机制研究
-
批准号:82070530
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2020
-
负责人:白玉作
-
依托单位:
miRNA-novel-272通过靶向半乳糖凝集素3调控牙鲆肠道上皮细胞炎症反应的机制研究
-
批准号:32002421
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:修云吉
-
依托单位:
m6A修饰介导的lncRNA WEE2-AS1转录后novel-pri-miRNA剪切机制在胶质瘤恶性进展中的作用研究
-
批准号:82072775
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2020
-
负责人:薛皓
-
依托单位:
miRNA/novel_167靶向抑制Dmrt1的表达在红鳍东方鲀性别分化过程中的功能研究
-
批准号:31902347
-
项目类别:青年科学基金项目
-
资助金额:25.0万元
-
批准年份:2019
-
负责人:闫红伟
-
依托单位: